[HTML][HTML] The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy

NN Kreis, F Louwen, J Yuan - Cancers, 2019 - mdpi.com
Loss of cell cycle control is characteristic of tumorigenesis. The protein p21 is the founding
member of cyclin-dependent kinase inhibitors and an important versatile cell cycle protein …

PCNA: structure, functions and interactions

Z Kelman - Oncogene, 1997 - nature.com
Proliferating cell nuclear antigen (PCNA) plays an essential role in nucleic acid metabolism
as a component of the replication and repair machinery. This toroidal-shaped protein …

Use of a cDNA microarray to analyse gene expression

J DeRisi, L Penland, M Bittner, PS Meltzer, M Ray… - Nat. genet, 1996 - nature.com
The development and progression of cancer1–3 and the experimental reversal of
tumorigenicity4, 5 are accompanied by complex changes in patterns of gene expression …

Effects of p21Cip1/Waf1 at Both the G1/S and the G2/M Cell Cycle Transitions: pRb Is a Critical Determinant in Blocking DNA Replication and in Preventing …

AB Niculescu III, X Chen, M Smeets… - … and cellular biology, 1998 - Taylor & Francis
It has been proposed that the functions of the cyclin-dependent kinase inhibitors
p21Cip1/Waf1 and p27Kip1 are limited to cell cycle control at the G1/S-phase transition and …

p21WAF1 and tumourigenesis: 20 years after

NA Warfel, WS El-Deiry - Current opinion in oncology, 2013 - journals.lww.com
Since its discovery, it has become increasingly clear that p21 can function as both a
classical tumour suppressor and an oncogene. In order to effectively utilize p21 as a …

Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks

S Huang, DE Ingber - Experimental cell research, 2000 - Elsevier
Development of characteristic tissue patterns requires that individual cells be switched
locally between different phenotypes or “fates;” while one cell may proliferate, its neighbors …

Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression

S Carreira, J Goodall, I Aksan, SA La Rocca… - Nature, 2005 - nature.com
The controls that enable melanoblasts and melanoma cells to proliferate are likely to be
related, but so far no key regulator of cell cycle progression specific to the melanocyte …

Differentiation therapy of human cancer: basic science and clinical applications

M Leszczyniecka, T Roberts, P Dent, S Grant… - Pharmacology & …, 2001 - Elsevier
Current cancer therapies are highly toxic and often nonspecific. A potentially less toxic
approach to treating this prevalent disease employs agents that modify cancer cell …

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer

TK MacLachlan, N Sang… - Critical Reviews™ in …, 1995 - dl.begellhouse.com
ABSTRACT A significant portion of cellular scientific literature published is dedicated to
describing the cloning, the link to cancer, or the characterization of proteins involved in the …

Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate …

X Zi, R Agarwal - Proceedings of the National Academy of Sciences, 1999 - pnas.org
Reduction in serum prostate-specific antigen (PSA) levels has been proposed as an
endpoint biomarker for hormone-refractory human prostate cancer intervention. We …